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Background: Patient age is one of many potential risk factors for fracture nonunion. Our hypothesis is that older
patients (≥60) with fracture risk factors treated with low-intensity pulsed ultrasound (LIPUS) have similar heal rate
(HR) to the population as a whole. We evaluate the impact of age in conjunction with other risk factors on HR in
LIPUS-treated patients with fresh fracture (≤90 days old).
Methods: The Exogen Bone Healing System is a LIPUS device approved in 1994 to accelerate healing of fresh
fracture. After approval, the FDA required a Post-Market Registry to assess performance. Patient data collected from
October 1994 until October 1998 were individually reviewed and validated by a registered nurse. Four distinct data
elements were required to report a patient: date fracture occurred; date treatment began; date treatment ended;
and a dichotomous outcome of healed v. failed, by clinical and radiological criteria. Data were used to calculate
two derived variables; days to treatment (DTT) and days on treatment (DOT). Every validated fresh fracture patient
with DTT, DOT, and outcome is reported.
Results: The validated registry had 5,765 patients with fresh fracture; 73% (N = 4,190) are reported, while 13% of
patients were lost to follow-up, 11% withdrew or were non-compliant, and 3% died or are missing outcome. Among
treatment-compliant patients, HR was 96.2%. Logistic estimates of the odds ratio for healing are equivalent for patients
age 30 to 79 years and all age cohorts had a HR > 94%. Open fracture, current smoking, diabetes, vascular insufficiency,
osteoporosis, cancer, rheumatoid arthritis, and prescription NSAIDs all reduced HR, but older patients (≥60) had similar
HRs to the population as a whole. DTT was significantly shorter for patients who healed (p < 0.0001).
Conclusions: Comorbid conditions in conjunction with aging can reduce fracture HR. Patients with fracture who used
LIPUS had a 96% HR, whereas the expected HR averages 93%. Time to treatment was significantly shorter among
patients who healed (p < 0.0001), suggesting that it is beneficial to begin LIPUS treatment early. Older patients (≥60)
with fracture risk factors treated with LIPUS exhibit similar heal rates to the population as a whole.
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Risk factors for fracture nonunion include patient age
and the medical comorbidities attendant to age, as well
as characteristics of the fracture itself [1]. The relation-
ship of patient age to fracture heal rate (HR) was clearly
demonstrated in a prospective study of 1,133 patients
with intracapsular fracture of the femoral neck treated
with internal fixation [2].* Correspondence: Grant.Steen@bioventusglobal.com
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unless otherwise stated.Few studies specifically address patient age as a risk
factor for nonunion. Nevertheless, every study that has a
broad inclusion range for age potentially has age as a
confounder of HR. While age may be a risk in itself, it is
also correlated with many known or suspected risk fac-
tors for nonunion [1]. For example, obesity increases
fracture risk even in young women [3]; yet body-mass
index (BMI) tends to increase with age [4] and with a
range of comorbid illnesses that also increase with age,
including diabetes, metabolic syndrome, insulin resist-
ance, and inflammation [5]. Cigarette smoking is a riskis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ing risks are dose-dependent and greatest among the
elderly [8]. Similarly, osteoporosis risk and fracture risk
increase with age [9], though young women with frac-
ture can have bone microarchitecture characteristic of
patients with osteoporosis [10]. Hence, to evaluate the
effect of patient age specifically on HR, it may be neces-
sary to assess many patients.
We report on the impact of age on HR among patients
with fresh fracture, defined as fracture ≤90 days old. We
used a 90-day cut-off because the Department of Health
and Human Services defined long bone nonunion as oc-
curring “when serial radiographs have confirmed that
fracture healing has ceased for three or more months
prior to starting treatment” [11]. Data are drawn from a
post-market registry of the Exogen device (Bioventus
LLC, Durham, NC), which has been published in part
previously [12,13]. This study reports on the full, vali-
dated data set, including twice the number of patients
reported previously. Our hypothesis is that older patients
(≥60) with fracture risk factors treated with low-intensity
pulsed ultrasound (LIPUS) have similar HR to the popu-
lation as a whole.
Methods
The Exogen Bone Healing System was approved by the
FDA in 1994 for accelerating the time-to-heal of fresh
fractures. The FDA required that the Exogen Post-
Market Registry be open for at least 2 years, beginning
in 1994 (study protocol available upon request). The
registry was set up and maintained by a third-party con-
sultant (Enterprise Software Solutions (ESS), Charlotte,
NC). The present study was designed as a single arm,
observational study of a convenience sample of consecu-
tive consenting patients who had enrolled prospectively
in the registry, and data were gathered and analyzed in a
blinded fashion.
This study was exempted from ethical approval by the
Institutional Review Board of Duke University Medical
Center because data were drawn from a registry meant
to satisfy U.S. Food and Drug Administration (FDA) re-
quirements. Patients signed an informed consent at
registry enrollment.
Data for the period from 14 Oct 1994 until 15 Oct
1998 were validated by a registered nurse who went
through every patient record manually and compared
the paper record to the digital record.
Inclusion criteria for the present analysis required four
distinct data elements for each patient:
 Date of fracture: Calendar date when the fracture
occurred.
 Date of LIPUS treatment: Calendar date when
LIPUS treatment began. Date that LIPUS treatment ended: Calendar date
when LIPUS treatment ended.
 Outcome: A dichotomous variable of healed or not
healed at treatment end. For a fracture to be
considered healed, the registry protocol specified that
a fracture had to meet both clinical and radiological
criteria:
○ No motion or crepitus at the fracture site and
free of pain on manual stress.
○ At least three of four cortices bridged on X-ray
views.
These data were used to calculate 2 derived variables
of interest, in addition to Outcome:
 Days-to-treatment (DTT): Time from fracture to
beginning of LIPUS treatment. DTT defined the
cohort of patients described here (DTT ≤ 90 days).
 Days-on-treatment (DOT): Time the patient used
LIPUS before attaining an outcome.
Additional patient data were analyzed for up to 181
different variables including:
 Patient demographics (e.g., age, sex, weight, height,
body-mass index (BMI), etc.);
 Bone fractured (e.g., clavicle, femur, humerus, radius,
scaphoid, tibia, ulna, etc.);
 Type of fracture (e.g., simple, closed, comminuted,
stress, displaced, open, etc.);
 Type of treatment (e.g., cast, screws, nails, plates,
external fixation, etc.).
 Medical comorbidities (e.g., smoking history, physician
diagnosis of diabetes, cancer, hypertension,
cardiovascular disease, osteoporosis, renal failure, etc.);
 Use of medications (e.g., analgesics, anticoagulants,
antidiabetics, bisphosphonates, calcium channel
blockers, diuretics, other cardiac medications,
NSAIDs, steroids, etc.).
The Exogen device has an integrated treatment coun-
ter which counts both treatment episodes and treatment
duration; this counter was downloaded to determine
whether the patient was compliant with treatment. Every
compliant patient in the manually-validated database
with fresh fracture (≤90 days old) was included in this
analysis, if DTT, DOT, and outcome data were available.
To address whether there was systematic loss to follow-
up in a specific risk group, patients with DTT, DOT, but
no treatment outcome, were contrasted with patients
with all necessary information. Patients with delayed
union or fracture nonunion (90–365 days old) or with
treatment-resistant fracture nonunion (>365 days old)
were not included in this analysis. Because patients were
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were available for comparison.
The t-statistic (Satterthwaite method for unequal vari-
ances) was used to compare means and Fisher’s exact test
was used to test for association in 2×2 tables. P-values <
0.01 are reported. We calculate 95% confidence intervals
(CIs) for percent healed point estimates. All data were an-
alyzed using SAS software, v9.3 (Cary, NC).
Results
The number of patients with complete records in the
validated registry is 7,884 (Table 1), of whom 4,190 pa-
tients had fresh fracture, defined as a fracture ≤90 days
old. Overall, 72.7% of all fresh fracture patients who re-
ceived LIPUS treatment are reported (=4,190/5,765),
while 12.8% of patients were lost to follow-up, 5.8% of
patients were deemed non-compliant, 5.3% of patients
withdrew from treatment, and 3.4% died or were missing
an outcome. We do not report HR on an intention-to-
treat (ITT) basis, because patient compliance is generally
low outside the context of a clinical trial [14]; the HR we
report is essentially efficacy with patient compliance.
Among 7,884 compliant registry patients, HR was 93.9%.
In the 4,190 patients with fresh fracture, the HR was
96.2% overall (Table 1).
Males comprised 58.4% of all patients, and the average
patient age was 43.3 years (Table 2). Patients lost to
follow-up were significantly younger than patients with a
treatment outcome (p < 0.0004), were somewhat heavier
(p < 0.002), and had smoked for a longer period of time
(p < 0.0002), but did not differ demographically in other
ways (Table 3).
Our data show clearly that age did not have any effect
on fracture HR, among patients age 30 or older (Figure 1).
For patients 20–29 years old, HR was significantly higher
than in older patients (p < 0.003). Logistic estimates of the
odds ratio for healing are equivalent for patients age 30 to
79 years, and the HR for 298 LIPUS-treated patients age
70 to 79 years was nearly identical to the overall HRTable 1 Summary of the disposition of fracture records in the
All fractures
Any record in the Registry 11,433
Deceased 42




Missing treatment outcome 447
Analyzed records in the Registry 7,884
Healed 7,402 (93.9%)
Failed 482 (6.1%)(Figure 1). All LIPUS-treated age groups had a HR > 94%
(Figure 1).
The relationship between patient age and fracture HR
may be confounded by certain risk factors that correlate
with age. For example, body-mass index (BMI) interacts
with patient age in a complex manner. Patients who are
obese generally do not heal as well as people of ideal
weight (Figure 2). Obese people older than age 60 have a
lower HR than either young obese people or elderly
(≥60 years of age) people who are not obese. Patients
under age 20 years, and underweight patients, have the
highest HR (Figure 2).
The HR with LIPUS was evaluated for each bone stud-
ied (Table 4). In the overall sample, open fractures, as
well as fractures of the tibia/fibula, femur, humerus,
clavicle, radius/ulna, and metacarpal had significantly
lower HR than the average of all bones, even when
treated with LIPUS. Fractures of the metatarsal, radius,
scaphoid, ankle, fibula, and ulna had significantly better
HR than average when treated with LIPUS. Bones of eld-
erly patients (>60 years old) had a similar HR to all pa-
tients, when treated with LIPUS.
We compared patients who healed with LIPUS to pa-
tients who failed to heal (Table 5). Patients who failed to
heal were on average 4.5 years older than patients who
healed (p < 0.0009). Days-to-treatment (DTT) was sig-
nificantly shorter for patients who healed (p < 0.0001);
this strongly suggests that it is beneficial to begin treat-
ment with LIPUS as soon as possible after fracture.
Days-on-treatment (DOT) was also significantly shorter
for patients who healed (p < 0.0001), but this would be
expected, as patients who failed to heal would likely
continue using the treatment for a longer time. Patients
with open fracture were more at risk of treatment fail-
ure (p < 0.002). Patients who failed to heal were also
likely to be using more medications (p < 0.003), al-
though there was no significant difference in the num-
ber of medical comorbidities between these two groups
(Table 5).Exogen Registry database









4,032 (96.2%) 2,709 (92.6%) 661 (86.2%)
158 (3.8%) 218 (7.4%) 106 (13.8%)
Table 2 Summary of patient demographic data
Variable Mean SD N Median
Age (years) 43.3 18.2 3,906 42.0
Weight (pounds) 171.0 43.3 3,108 170.0
Height (inches) 67.9 4.7 3,120 68.0
Body-Mass Index 25.9 5.5 3,092 25.1
This table includes 2,298 men (58.4% of the sample) and 1,639 women (41.6%
of the sample) with fresh fracture.
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able to the overall patient sample (Table 6). Patients with
diagnosed cardiovascular or renal disease had a HR better
than average. But patients who smoked or had diabetes,
vascular insufficiency, osteoporosis, cancer, or rheumatoid
arthritis had a lower HR than average. Nevertheless, there
was not a clinically significant difference in HR as a func-
tion of comorbidity among LIPUS-treated patients, and
elderly patients had a HR comparable to the overall sam-
ple (Table 6).
Patients taking analgesics, prescription NSAIDs, antico-
agulants, steroids, antibiotics, insulin, or calcium channel
blockers were impaired in HR, compared to the overall co-
hort of patients (Table 7). However, patients taking non-
prescription NSAIDs were not impaired in healing.
Discussion
Patients with fresh fracture who used LIPUS had a 96%
HR (Table 1), whereas the HR from the literature aver-
ages 93% [15-20]. Thus, LIPUS may have reduced the
nonunion rate by up to 40%, with respect to that litera-
ture [15-20]. Age did not have a significant impact on
fracture HR, and the HR for patients aged 30 to 79 years
was equivalent (Figure 1). However, HR is confounded
by other risk factors for nonunion, such as elevated BMITable 3 Comparison of patients with an outcome in the regis
Outcome (± SD) N or
Patient age (years) 43.3 (±18.1) 4,15
Weight (lb) 170.5 (±43.0) 3,29
Height (in) 67.9 (±4.7) 3,30
Body-mass index 25.9 (±5.5) 3,27
Days-to-treatment (mean) 38.6 (±24.5) 4,17
Days-on-treatment (mean) 118.5 (±86.0) 4,19
Female (vs. male) (%)** 1,745 (vs. 2,441) 41.7
Open (vs. closed fracture) (%)** 710 (vs. 3,320) 17.6
Number of prior procedures (mean) 1.5 (±0.8) 991
Number of comorbidities (mean) 1.4 (±0.7) 763
Number of medications (mean) 0.4 (±0.7) 2,74
Smoking years (mean) 5.1 (±10.6) 3,18
This approach should be very sensitive to risk factors that increase the risk of loss t
an asterisk (**), which were tested using Fischer’s exact test because they are dicho(Figure 2). Fracture HR varies as a function of the bone
broken (Table 4), but the most compelling risks for
treatment failure are patient age, open fracture, treat-
ment delay, and use of medications (Table 5). HR can be
reduced by medical comorbidities (Table 6) and by med-
ications such as prescription NSAIDs, anticoagulants,
steroids, and calcium channel blockers (Table 7). Unlike
prescription NSAIDs, non-prescription NSAIDs do not
have a significant effect on HR (Table 7).
Evaluation of LIPUS-treated patients over age 30 did
not show the decline in HR (Figure 1) often described in
the literature [15-20]. However, patients who failed to
heal with LIPUS (Table 5) were significantly older than
patients who did heal. We surmise that this apparent dis-
crepancy is explained by LIPUS-treated patients under age
30, who healed well and reduced the average age of healed
patients (Table 5).
There is strong evidence in the literature that increas-
ing age is associated with impaired fracture healing
[2,21,22]. Femoral neck HR decreased with age, both in
displaced (p < 0.001) and non-displaced (p < 0.003) frac-
tures [2]. Among patients under age 60, just 7 of 106
had fracture nonunion (HR = 93.4%); among patients age
70 to 80 years, 84 of 337 had nonunion (HR = 75.1%)
[2]. In a separate study, patients with displaced femoral
neck fracture who developed nonunion were signifi-
cantly older than patients with normal healing [21].
Nevertheless, in a third study, age was not identified as a
predictor of nonunion in 202 patients with intracapsular
femoral neck fracture [22].
Patient age has an impact on tibial healing in the ab-
sence of LIPUS [23-26]. Among 42 patients treated sur-
gically for tibial plateau fracture, the failure rate was just
7% in young patients, but increased to 79% in patients
older than age 60 [23]. Age was a risk factor for totaltry to patients lacking an outcome
% No outcome (± SD) N or % Significance
7 41.4 (±17.9) 1,539 0.0004
6 176.5 (±55.8) 1,030 0.002
9 68.4 (±4.4) 1,031 0.0004
8 26.4 (±7.8) 1,021 NS
0 39.6 (±25.3) 1,567 NS
0 116.4 (±107.0) 1,561 NS
% 599 (vs. 957) 38.5% NS
% 243 (vs. 1,245) 16.3% NS
1.4 (±0.7) 368 NS
1.5 (±0.9) 250 NS
7 0.4 (±0.6) 755 NS
3 6.6 (±11.3) 1,041 0.0002
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Figure 1 Summary of the effect of patient age on heal rate (%). The heal rate (HR) for each decade in shown, together with the upper and
lower 95% confidence interval (CI) for each HR estimate. The HR is significantly higher than the overall HR only in patients age 20–29 years of age
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Figure 2 Effect of age and BMI on heal rate (HR). HR shows a decreasing trend with increasing weight, but HR tends to cluster by age, except
in obese patients more than 60 years old. This suggests that BMI generally has more impact on HR than does patient age.
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Table 4 Summary of heal rate by bone
Overall Heal Elderly Heal
Comorbidity Healed Failed Rate Lower CI Upper CI Healed Failed Rate
All fractures 4,032 158 96.2% 95.7% 96.8% 780 38 95.4%
All closed fractures 3,212 108 96.7% 96.1% 97.4% 650 27 96.0%
All open fractures 147 9 94.2% 90.6% 97.9% 24 0 100.0%
Tibia 939 42 95.7% 94.5% 97.0% 170 9 95.0%
Tibia/Fibula 705 33 95.5% 94.0% 97.0% 140 7 95.2%
Femur 412 19 95.6% 93.7% 97.5% 136 4 97.1%
Metatarsal 423 7 98.4% 97.2% 99.6% 40 0 100.0%
Radius 337 2 99.4% 98.6% 100.0% 94 1 98.9%
Humerus 207 19 91.6% 88.0% 95.2% 60 11 84.5%
Scaphoid 203 6 97.1% 94.9% 99.4% 11 0 100.0%
Clavicle 120 7 94.5% 90.5% 98.5% 7 1 87.5%
Ankle 122 3 97.6% 94.9% 100.0% 31 2 93.9%
Radius/Ulna 144 7 95.4% 92.0% 98.7% 36 0 100.0%
Fibula 96 2 98.0% 95.2% 100.0% 7 0 100.0%
Ulna 84 2 97.7% 94.5% 100.0% 14 0 100.0%
Metacarpal 42 2 95.5% 89.3% 100.0% 4 0 100.0%
Every bone represented in the database by more than 50 fractures is tabulated. Column totals do not always add up because some information is missing; for
example, some fractures were not defined as either open or closed. The total of all bones is larger than the total count of patients because some patients broke
multiple bones. The heal rate (HR) in humerus is significantly lower than the overall HR because the confidence interval (CI) for humerus does not overlap the CI
for “All fractures.” Bolded HR numbers are above the CI associated with “All fractures.” Italic HR numbers are below the CI associated with “All fractures.” In the
“Elderly” group, bolded HR numbers are above the CI for the corresponding fracture in the whole cohort, while italic HR numbers are below the CI for the
corresponding fracture in the whole cohort. Elderly HR is comparable to the HR of the overall sample.
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tibial plateau fracture [24]. Increasing patient age was as-
sociated with worse surgical outcomes after tibial sur-
gery [25,26]. Yet age was not noted as a nonunion risk
factor in studies of 211 patients with long bone fracture
[20] or 416 patients with tibial shaft fracture [27].
Age can also have an impact on healing in humeral
fracture. A retrospective review of nonunions of theTable 5 Comparison of fresh-fracture patients who healed wi
Healed (± SD) N
Patient age (years) 43.2 (±18.1) 4,0
Weight (lb) 170.4 (±43.1) 3,1
Height (in) 67.9 (±4.7) 3,1
Body-mass index 25.8 (±5.5) 3,1
Days-to-treatment (mean) 38.3 (±24.3) 4,0
Days-on-treatment (mean) 115.6 (±83.1) 4,0
Female (vs. male) (%)** 1,674 (vs. 2,356) 41
Open (vs. closed fracture) (%)** 669 (vs. 3,212) 17
Number of prior procedures (mean) 1.4 (±0.8) 95
Number of comorbidities (mean) 1.4 (±0.7) 72
Number of medications (mean) 0.4 (±0.7) 2,6
Smoking years (mean) 5.0 (±10.6) 3,0
This approach should be very sensitive to risk factors that increase the risk of treatm
an asterisk (**), which were tested using Fischer’s exact test because they are dichomidshaft humerus concluded that advanced age accounted
for 57% of nonunions [28]. A prospective study of 110 eld-
erly patients with humeral diaphyseal fracture found that
nonunion was predicted by patient age (p < 0.05), prior
stroke (p < 0.001), or prior nonunion (p < 0.001) [29]. In a
review of 37 patients with humeral fracture, the nonunion
rate was 10.8% and patient age was the only significant
predictor of humeral nonunion [30]. Finally, age is a riskth LIPUS to patients who did not heal
or % Failed (± SD) N or % Significance
00 47.7 (±16.7) 157 0.0009
66 173.9 (±41.9) 130 NS
81 67.0 (±4.4) 128 NS
50 26.9 (±5.8) 128 NS
13 47.1 (±27.3) 157 0.0001
32 193.0 (±119.7) 158 <0.0001
.5% 71 (vs. 85) 45.5% NS
.2% 41 (vs. 108) 27.5% 0.002
0 1.6 (±1.2) 41 NS
7 1.4 (±0.5) 36 NS
39 0.7 (±0.9) 108 0.003
62 7.2 (±11.8) 121 NS
ent failure. The p values shown are from T-tests, except for comparisons with
tomous variables.
Table 6 Impact of comorbidity on heal rate (HR) in the fresh fracture cohort
Overall Heal Elderly Heal
Comorbidity Healed Failed Rate Lower CI Upper CI Healed Failed Rate
All fractures 4,032 158 96.2% 95.7% 96.8% 554 28 95.2%
Current smokers 652 35 94.9% 93.3% 96.5% 81 1 98.8%
Diabetes 224 11 95.3% 92.6% 98.0% 110 4 96.5%
Hypertension 188 7 96.3% 93.6% 99.0% 83 2 97.6%
Vascular insufficiency 107 5 95.5% 91.7% 99.4% 56 2 96.6%
Osteoporosis 80 5 94.1% 89.1% 99.1% 57 5 91.9%
Cancer 77 4 95.1% 90.3% 99.8% 50 2 96.2%
Cardiovascular disease 60 2 97.2% 93.3% 100.0% 54 2 96.4%
Alcoholism 68 3 95.8% 91.1% 100.0% 10 0 100.0%
Renal disease 44 1 97.8% 93.5% 100.0% 11 1 91.7%
Rheumatoid arthritis 36 4 90.0% 80.7% 99.3% 21 3 87.5%
The overall heal rate (HR) includes all patients, even if they have comorbidities or are older than age 60. Then various comorbidities are broken out, for the entire fresh
fracture cohort overall, and for the elderly cohort (≥60 years of age) specifically. Bolded HR numbers are above the CI associated with “All fractures.” Italic HR numbers
are below the CI associated with “All fractures.” In the “Elderly” group, bolded HR numbers are above the CI for the corresponding fracture in the whole cohort, while
italic HR numbers are below the CI for the corresponding fracture in the whole cohort. Elderly HR is comparable to the HR of the overall sample.
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with clavicular fracture, patient age was an important pre-
dictor of nonunion [31], and older patients with clavicular
fracture typically had a higher risk of nonunion [32,33].
Our data suggest that patients who are obese generally
do not heal as well as people of ideal weight (Figure 2).
Obesity has been recognized as a risk factor for fracture
nonunion for decades [34], and BMI is significantly
higher in patients with failed reduction of the distal tibia
[35]. Obesity (BMI ≥30) is also a significant risk factor
(p < 0.01) for required revision of total hip replacement
after femoral neck fracture [36], and BMI is known to
interact with risk factors for nonunion, including smok-
ing [37].
A major strength of the registry database is the size of
the cohort, which we believe to be the largest everTable 7 Impact of current medication use on heal rate (HR) in
Overall Heal
Medication Healed Failed Rate
No medications at all 1,765 61 96.7%
Non-NSAID analgesic 301 19 94.1%
Prescription NSAIDs 159 14 91.9%
Anticoagulants 107 9 92.2%
Non-prescription NSAIDs 104 3 97.2%
Steroids 93 8 92.1%
Antibiotics 80 4 95.2%
Insulin 75 6 92.6%
Calcium channel blockers 62 6 91.2%
The overall average includes all patients, even if they use medications or are older
fracture cohort overall, and for the elderly cohort (≥60 years of age) specifically. The
confidence interval (CI) for each HR estimate. Italic HR numbers are below the CI ass
the CI for the corresponding fracture in the whole cohort. Elderly HR was comparabreported. This enabled us to gain insight into complex
relationships. For example, BMI interacts with patient
age in a complex way (Figure 2); obese patients generally
do not heal as well as non-obese patients. Patients older
than age 60 who are obese have a substantially lower HR
than either young obese patients or elderly (≥60 years of
age) patients of ideal weight. This could be because pa-
tients who are elderly and obese can have a range of
other health problems, including diabetes, hypertension,
and vascular insufficiency (Table 6), and may be taking
various medications (Table 7). Conversely, patients under
age 20, or underweight patients, have a higher HR than
other patient groups (Figure 2).
A second strength of this study is that patients en-
rolled in the registry did not differ in obvious ways from
a random sample of fracture patients. Roughly 16.2% ofthe fresh fracture cohort
Elderly Heal
Lower CI Upper CI Healed Failed Rate
95.8% 97.5% 228 11 95.4%
91.5% 96.7% 48 4 92.3%
87.8% 96.0% 40 4 90.9%
87.4% 97.1% 54 2 96.4%
94.1% 100.0% 31 0 100.0%
86.8% 97.3% 30 5 85.7%
90.7% 99.8% 14 2 87.5%
86.9% 98.3% 36 2 94.7%
84.4% 97.9% 37 3 92.5%
than age 60. Then various medications are broken out, for the entire fresh
HR for each comorbidity in shown, together with the upper and lower 95%
ociated with “All fractures.” In the “Elderly” group, italic HR numbers are below
le to the HR of the overall sample.
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which is consistent with the 18.1% of people who are
currently smokers in the United States [38]. Roughly
5.6% of registry patients had diabetes, which is compar-
able to the 6.6% of Americans age 45 to 64 years who
had diabetes in 1996 [39], the median year in the regis-
try. Roughly 4.7% of registry patients had hypertension,
somewhat less than the 10.5% of Americans (age 18–44
years) who had a diagnosis of hypertension between
2005 and 2008 [40].
A limitation of this study is that blinding was impos-
sible, and patients may have been motivated to perceive
a treatment benefit, even if none existed. Because the
registry collated outcomes from treatment, it is a thera-
peutic study, and therapeutic studies are stronger, when
blinded [41]. Results reported herein are a retrospective
analysis of standardized, prospectively-collected treat-
ment data, so they provide Level III evidence [41]. Yet
the large number of patients (N = 4,190; see Table 1) and
the relatively high rate of retention (73%; see Table 1),
may overcome some of the limitations inherent to a
registry study [42].
A second limitation of this study is that the data are as
much as 20 years old. It has been argued that fracture
management has not changed substantially since the regis-
try opened [43]. Intramedullary nailing was accepted as
treatment for long bone fracture prior to when the bulk
of the registry patients were enrolled [44]. Therefore,
many of the registry patients appropriate for nailing may
have received that treatment. We cannot exclude the no-
tion that changes in patient management may have had
an impact on HR of patients in the registry, but we be-
lieve that such changes were probably evolutionary, not
revolutionary.
A third limitation of our work is that registry studies
typically capture a limited dataset based on clinical con-
venience, sacrificing data granularity for breadth of clin-
ical capture. While it would be useful to have more
detailed information about the precise location of each
fracture within the bone, or the extent of associated soft
tissue injury, or even why the physician elected to treat
a fracture with LIPUS, these fields were not in the
database.
A final limitation of this study is that the calculated
number-needed-to-treat (NNT) for patients is currently
33, in order to avoid one nonunion. However, this calcu-
lation is misleading. If fresh fracture patients are selected
for treatment based on the clinical understanding of risk
factors contemporary with registry enrollment, then
NNT would be 33. But a combination of advanced age
and obesity decreases the HR substantially (Figure 2),
and patients who are aged, obese, and diabetic may show
a further reduction of HR. Therefore, the NNT for an
aged, obese, and diabetic patient may be lower than 33,although a multivariate analysis will be required to test
this hypothesis.
It is very important that fracture treatment in the eld-
erly be effective, because there can be severe conse-
quences of even brief physical inactivity. Sarcopenia is
the loss of lean muscle mass that occurs even with exer-
cise during healthy aging [45]. Elderly adults lose muscle
mass and lean body tissue far more rapidly than do
young adults during prolonged physical inactivity [46].
Ten days of experimental bed rest in otherwise-healthy
67-year-old adults resulted in a 14% loss of power, a 13%
loss of strength, and a 12% loss of aerobic capacity [47].
Though physical performance was not impaired by bed
rest among healthy adults [47], one might expect phys-
ical performance to be diminished in adults with frac-
ture. Elderly patients hospitalized with acute illness
experience a rapid functional decline [48]; among 71 pa-
tients (average age = 74 years), two-thirds experienced a
functional decline by the second day in hospital. Assess-
ments of physical mobility, toileting, incontinence, feed-
ing, grooming, and mental status showed a continued
decline during hospitalization in 10% of patients, and
most patients had no improvement in functional ability
until after release from the hospital [48]. A more recent
study involving 2,293 patients (age ≥70) showed that
one-third of patients declined in activities of daily living
between hospitalization and discharge [49]. The fre-
quency of functional decline increased markedly with
age: 23% of patients aged 70–74 declined in function,
but 63% of patients >90 years old experienced such a de-
cline [49]. Femoral neck fracture in the elderly is associ-
ated with a 5-fold elevation in risk of mortality in 1 year,
with deficits in mobility, respiratory and renal function,
cognition, and endocrine function [50]. If LIPUS can be
used to mitigate age as a risk factor for healing, then the
severe impact of physical inactivity post-fracture can po-
tentially be minimized.
Conclusions
Our results suggest that older age can be mitigated as a
risk factor for impaired fracture healing when LIPUS is
used (Figure 1). Early use of LIPUS is associated with
fracture healing in 96.2% of patients overall (Table 1) and
in 95.2% of the elderly (Table 6). Medical comorbidities
(e.g., smoking, diabetes, vascular insufficiency, osteopor-
osis, cancer, and rheumatoid arthritis; Table 6), and use of
medications (e.g., prescription NSAIDs, anticoagulants,
steroids, antibiotics, insulin, and calcium channel blockers;
Table 7) may increase the risk of nonunion in the elderly.
Yet elderly patients treated with LIPUS have a HR com-
parable to young patients (Figure 1) and delays in using
LIPUS are associated with non-healing fracture (Table 5).
Hence, we recommend that elderly patients with risk fac-
tors for nonunion be treated with LIPUS soon after injury.
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